Deutsche Bank releases pledge on 7.39% Piramal Pharma shares

Pledge releasedOwnership Changes View source PDF Explain this filing

PPLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.9%Reaction day

₹204.50

prior close

₹209.49

announcement price

In-mkt

timing

Nifty Smallcap 250market+0.2%+2.7% vs market

Pharmaceuticals peers, median of 175sector+0.0%+2.9% vs sector

On the reaction day the stock moved 2.7 pts more than Nifty Smallcap 250 and 2.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.1

15m

+0.1

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.9+0.2+2.7+0.0+2.9

Next day

+2.5-0.4+2.9-0.6+3.0

+6.0+0.1+5.8-0.2+6.1

+4.3+0.6+3.7-0.2+4.5

+3.9+0.3+3.5-0.4+4.3

+1.6+0.2+1.4-0.7+2.3

+5.1+0.7+4.5-0.6+5.7

15d

+10.5+1.2+9.3+1.6+8.9

+1.8-0.1+1.9+1.7+0.1

-5.1-4.8-0.3-3.9-1.3

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 175Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Deutsche Bank AG, acting as onshore security agent for lenders, released its pledge on 98.4 million equity shares (7.39% of share capital, 7.43% of voting capital) of Piramal Pharma that were pledged by borrower CA Alchemy Investments. Release was done on 13 August 2026 to enable a permitted sale transaction under the facility agreement. After release, pledge remains on 140.26 million shares (10.54%). Deutsche Bank holds no beneficial interest in the shares.

Likely market impact

Frees up 7.39% stake held by CA Alchemy for a potential block sale. Watch for a separate sale announcement which could weigh on the stock in the near term.